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follow‐up	study	evaluates	 the	 long‐term	outcomes	of	all	 children	born	 to	mothers	
who	participated	in	the	ProTWIN	trial	at	4	years	of	age.














Several	 interventions	 are	 known	 for	 their	 use	 in	 preterm	












ing	 no	 beneficial	 effect	 of	 a	 cervical	 pessary	 in	 the	 short‐term	 in	
unselected	 women	 with	 an	 asymptomatic	 multiple	 pregnancy.	 In	
women	with	a	midtrimester	short	cervix	(cervical	 length	<38	mm),	




ter	 short	 cervix,	 showed	 a	 significant	 reduction	 in	 the	 composite	
outcome	 of	 death	 or	 survival	with	 a	 neurodevelopmental	 disabil‐







comes	 are	 studied	 in	 the	 subgroup	of	women	with	 short	 cervix	
(<38	mm).	Finally,	 the	composite	outcome	of	death	or	abnormal	
developmental	and/or	behavioral	and/or	physical	outcome	at	age	
4	 is	 explored	 in	 the	 offspring	 of	 all	 randomized	 women	 of	 the	
ProTWIN	trial,	as	well	as	in	the	subgroup	of	women	with	a	short	
cervix.
2  | MATERIAL AND METHODS
We	 performed	 a	 follow‐up	 study	 of	 the	 ProTWIN	 trial,	 a	 multi‐
center	randomized	controlled	clinical	trial	(NTR1858)	conducted	in	
40	hospitals	in	the	Netherlands.	Protocol	and	initial	results	of	this	
study	 have	 been	 described	 in	 detail	 elsewhere.10,11	 In	 short,	 the	
ProTWIN	trial	randomized	women	with	an	asymptomatic	multiple	
pregnancy	 between	 pessary	 (n	 =	 403)	 and	 usual	 care	 (n	 =	 410).	
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Key message
In	 offspring	 of	 women	 with	 a	 multiple	 pregnancy	 rand‐
omized	to	cervical	pessary	or	no	intervention,	cervical	pes‐
sary	did	not	 improve	 child	outcome	 in	 surviving	 children	
at	age	4.
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2.1 | Follow‐up assessment
We	aimed	to	evaluate	all	children	born	 in	the	ProTWIN	trial	who	
were	 alive	 at	 discharge	 at	 a	 corrected	 age	of	 4	 years,	 calculated	
from	 the	 expected	 date	 of	 delivery.	 Research	 nurses	 in	 partici‐
pating	 centers	 crosschecked	 medical	 records	 of	 all	 participating	
children	 of	 the	 original	 trial	 to	 track	 the	 possible	 occurrence	 of	
death	of	one	or	both	children	before	contacting	women.	Mothers	
of	whom	at	least	one	of	the	children	was	alive	were	contacted	by	
telephone	3	months	prior	 to	 the	 corrected	 age	of	4	 years.	After	
consent,	 questionnaires	were	 sent	 and	 filled	 out	when	 the	 child	
was	 the	 corrected	 age	 of	 4.	 Parents	 were	 asked	 to	 complete	 a	
paper	 version	 of	 the	 Ages	 and	 Stages	Questionnaire	 48	months	
(ASQ),13	 the	 Strengths	 &	Difficulties	 Questionnaire	 (SDQ)14 and 
a	 general	 health	 questionnaire.	 All	mothers	 provided	written	 in‐
formed consent.
2.2 | Ages and Stages Questionnaire
The	 ASQ	 is	 a	 developmental	 screening	 tool	 that	 covers	 five	 do‐










2.3 | Strengths & Difficulties Questionnaire








upon	data	validated	 in	the	Netherlands.14	 In	the	analysis,	 the	total	
difficulties	 score	 was	 treated	 as	 a	 binary	 variable,	 with	 a	 cut‐off	
score of 15 to define abnormal.14,17




















naires	were	 analyzed	 according	 to	 randomization	 in	 the	 ProTWIN	




children	 that	 participated	 in	 the	 follow	 up	were	 calculated	with	 t 
test,	Mann‐Whitney	U	 test,	 Chi‐square	 test	 or	 Fisher's	 exact	 test	
when	appropriate.	Also	differences	 in	characteristics	between	fol‐










were	 listed	as	potential	 confounders:	 parental	 education,	 smoking	
during	 pregnancy,	 ethnicity,	 bilingualism,	 whether	 the	 twins	 were	





Results	 of	 the	 general	 health	 questionnaire	 were	 clustered.9 
We	also	performed	an	exploratory	analysis	evaluating	the	effect	of	
pessary	on	a	 composite	outcome	of	death	or	 survival	with	 abnor‐
mal	child	outcome	in	the	offspring	of	all	randomized	women	of	the	
ProTWIN	study	and	in	the	subgroup	of	women	with	cervical	length	















increase	 in	patient	numbers	 in	 the	extrapolated	data.	Additionally,	
F I G U R E  1  Flowchart	of	participants	in	the	ProTWIN	trial	(unselected	and	subgroup	of	women	with	short	cervix),	starting	from	
randomization	of	women	with	a	multiple	pregnancy	until	the	4‐y	follow	up	of	the	children	[Colour	figure	can	be	viewed	at	wileyonlinelibrary.
com]
     |  5SIMONS et al.




Ethical	 approval	 for	 this	 follow‐up	 assessment	 was	 given	 by	 the	


















provided	 (n	=	287,	89%).	Eventually,	 questionnaires	were	 received	






origin	 compared	with	women	 that	were	 lost	 to	 follow	up	 (96%	vs	
88%,	P	<	.001)	(Table	S1).	No	other	differences	in	maternal	or	neo‐
natal	characteristics	between	these	two	groups	were	found.	When	
comparing	 maternal	 and	 neonatal	 characteristics	 of	 mothers	 and	
children	 participating	 in	 follow	 up,	 no	 differences	 were	 seen	 be‐
tween	 the	 pessary	 and	 control	 groups.	 The	mean	 age	 of	 children	
assessed	for	follow	up	was	3.98	(SD	.19)	years	in	the	pessary	group	
compared	with	3.96	 (SD	 .21)	years	 in	 the	control	 group	 (P	=	 .198)	
(Table	1).
3.1 | Ages and Stages Questionnaires, 
Strength and Difficulties Questionnaires and General 
Health outcomes
No	 significant	 differences	 were	 found	 in	 delayed	 or	 mean	 ASQ	
scores,	 abnormal	 SDQ	 scores	 and	physical	 problems	between	 the	
pessary	and	control	groups	(Tables	2	and	S2).	No	differences	were	
seen	 in	 the	 individual	 SDQ	 subscales	 (results	 not	 shown)	 or	 the	
individual	 items	 of	 physical	 problems	 (ie,	 use	 of	 healthcare,	medi‐
cation	and	number	of	hospital	 admissions	or	 surgeries)	 (Table	S3).	
When	 abnormal	 scores	of	ASQ,	 SDQ	and	physical	 problems	were	
combined,	 64	 (23%)	 pessary	 children	 vs	 37	 (16%)	 control	 children	




3.2 | A composite outcome of death or abnormal 
child outcome
















caution,	 since	an	extrapolation	 technique	 is	used	 to	 substitute	 for	
67%	of	the	children	that	were	lost	to	follow	up.	When	exploring	best	
and worst case scenarios, a consistent beneficial effect of pessary 
was	seen	in	the	subgroup	of	women	with	short	cervix	(Table	S4).
4  | DISCUSSION
In	 this	 follow‐up	 study,	we	 assessed	 child	 outcomes	 at	 4	 years	 of	
age	 in	 children	 born	 to	 mothers	 randomized	 to	 treatment	 with	 a	











after	 child	 birth.	 Furthermore,	 the	 ProTWIN	 trial	 is	 the	 first	 study	
to	 report	 on	 the	 long‐term	 effects	 in	 children	 born	 to	 all	mothers	
treated	with	a	cervical	pessary	in	their	pregnancy	to	prevent	preterm	
delivery.	To	date,	two	other	randomized	controlled	trials	have	been	
6  |     SIMONS et al.
TA B L E  1  ProTWIN	maternal	baseline	characteristics,	pregnancy	outcomes	and	child	neonatal	and	sociodemographic	characteristics	of	
the	women	participating	in	the	4‐y	follow‐up	study
Maternal characteristics at entry of the ProTWIN trial n/na
Pessary group  
(n = 140)
Control group 
(n = 118) P value
Median	(IQR)	maternal	age	at	randomization 140/118 32	(29‐36) 33	(30‐37) 0.471
Nulliparity,	n	(%) 140/118 87	(62.1) 66	(55.9) 0.312
Smoking	during	pregnancy,	n	(%) 139/114 4	(2.9) 5	(4.4) 0.735
Previous	preterm	delivery,	n	(%)b 51/52 10	(19.6) 7	(13.5) 0.438
Parental	education,	n	(%)c
High 134/115 102	(76.1) 89	(77.4) 0.908
Middle 20	(14.9) 15	(13.0)
Low 12	(9.0) 11	(9.6)
Ethnic	origin	European,	n	(%) 140/118 132	(94.3) 106	(89.8) 0.234
Monochorionic	pregnancy,	n	(%) 139/118 33	(23.7) 30	(25.4) 0.755
Triplet	pregnancy,	n	(%) 140/118 5	(3.6) 2	(1.7) 0.459
Cervical	length	(mm),	median	(IQR)
Unselected	group 140/118 43	(37‐48.75) 43	(39‐49) 0.268
Subgroup	cervical	length	<38	mm 43/18 35	(33‐37) 34	(32‐35.25) 0.100
Maternal	pregnancy	outcomes	ProTWIN	trial
Pregnancy	duration	in	weeks	median	(IQR) 140/118 36.6	(34.4‐37.6) 36.3	(34.2‐37.4) 0.417
<28	wk,	n	(%) 2	(1.4) 2	(1.7) >0.999
<32	wk,	n	(%) 14	(10.0) 13	(11.0) 0.790
<37	wk,	n	(%) 71	(50.7) 62	(52.5) 0.770
PPROM,	n	(%) 125/99 16	(12.8) 12	(12.1) 0.879
Tocolytic	drug,	n	(%) 140/118 23	(16.4) 21	(17.8) 0.771
Corticosteroids,	n	(%) 131/113 33	(25.2) 35	(31.0) 0.315
Neonatal characteristics of the ProTWIN trial n/n
Pessary group  
(n = 281)
Control group 
(n = 233) P value
Male	gender,	n	(%) 281/233 138	(49.1) 122	(52.4) 0.463
Composite	primary	outcome	of	the	ProTWIN	trial,	n	(%)d 279/233 15	(5.4) 15	(6.4) 0.611
Congenital	anomalies,	n	(%) 277/233 9	(3.2) 9	(3.9) 0.811
Birthweight,	n	(%)
<2500	g 280/233 147	(52.5) 134	(57.5) 0.256
<1500	g 32	(11.4) 22	(9.4) 0.465
Social	background	of	the	children	at	4	y	of	age
Age	at	follow‐up,	mean	(SD) 281/233 3.98	(0.19) 3.96	(0.21) 0.198
Living	in	two	parent	family,	n	(%)e 275/233 269	(97.8) 230	(98.7) 0.517
Twins	are	eldest	of	the	siblings,	n	(%) 277/233 169	(61.0) 128	(54.9) 0.166
Dutch	primary	language	spoken	at	home,	n	(%) 275/231 269	(97.8) 229	(99.1) 0.300
Bilingual,	n	(%) 277/233 40	(14.4) 34	(14.6) 0.961
Daycare,	n	(%) 277/233 256	(92.4) 217	(93.1) 0.757














A	 limitation	 of	 this	 study	 is	 the	 high	 rate	 of	 loss	 to	 follow	up,	







initially	 recruited	 30	 women	 did	 not	 collaborate	 in	 the	 follow‐up	
study.	We	expect	that	these	data	will	be	missing	at	random	and	will	







































OR unadjusted for  
confounders (95% CI)
OR adjusted for  
confounders (95% CI)c
ASQ,	delayed,	n	(%)b 277/229 41	(14.8) 23	(10) 1.54	(0.83‐2.85) 1.44	(0.77‐2.70)1
SDQ,	abnormal,	n	(%)b 279/229 19	(6.8) 10	(4.4) 1.37	(0.66‐2.82) 1.31	(0.64‐2.71)2
Physical	problemd 277/229 12	(4.3) 6	(2.6) 1.28	(0.57‐2.91) —3
Abnormal	child	outcomee 281/233 64	(22.9) 37	(15.9) 1.58	(0.94‐2.65) —4





OR unadjusted for  
confounders (95% CI)
OR adjusted for  
confounders (95% CI)c
ASQ,	delayed,	n	(%)b 85/34 9	(10.6) 3	(8.8) 1.26	(0.27‐5.96) 1.62	(0.34‐7.64)5
SDQ,	abnormal,	n	(%)b 85/34 4	(4.7) 0 2.08	(0.22‐19.34) 1.92	(0.20‐18.27)6
Physical	problemd 85/34 2	(2.4) 4	(11.8) 0.33	(0.07‐1.47) 0.42	(0.09‐2.03)7



























parable	 neurodevelopmental	 outcomes.	 Translating	 these	 results	
into	clinical	practice	combining	the	risk	of	death	and	an	abnormal	
developmental	 outcome,	 six	 to	 eight	women	with	 a	 short	 cervix	
need	 to	 be	 treated	with	 a	 cervical	 pessary	 to	 prevent	 one	 child	
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